Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Check-Cap Ltd. (CHEK)

0.6687
-0.0001
(-0.01%)
At close: April 24 at 4:00:00 PM EDT
0.6403
-0.03
(-4.26%)
Pre-Market: 8:05:33 AM EDT
Loading Chart for CHEK
  • Previous Close 0.6688
  • Open 0.6373
  • Bid --
  • Ask --
  • Day's Range 0.6372 - 0.6688
  • 52 Week Range 0.5600 - 3.0400
  • Volume 13,360
  • Avg. Volume 164,501
  • Market Cap (intraday) 3.913M
  • Beta (5Y Monthly) -0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -2.1400
  • Earnings Date May 13, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

www.check-cap.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CHEK

View More

Performance Overview: CHEK

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CHEK
32.45%
S&P 500 (^GSPC)
6.75%

1-Year Return

CHEK
69.88%
S&P 500 (^GSPC)
8.15%

3-Year Return

CHEK
91.01%
S&P 500 (^GSPC)
28.40%

5-Year Return

CHEK
93.43%
S&P 500 (^GSPC)
93.35%

Compare To: CHEK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CHEK

View More

Valuation Measures

Annual
As of 4/24/2025
  • Market Cap

    3.91M

  • Enterprise Value

    -20.84M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    0.23

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -33.21%

  • Return on Equity (ttm)

    -53.03%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -12.56M

  • Diluted EPS (ttm)

    -2.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    17.82M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -10.49M

Research Analysis: CHEK

View More

Company Insights: CHEK

Research Reports: CHEK

View More

People Also Watch